OnconiX AG transforms cancer care by replacing trial-and-error with test-before-treat precision. Using patient-derived tumor models and AI, we predict treatment response in days, enabling personalized therapy selection that improves outcomes and reduces unnecessary toxicity for patients with cancer.
Some insights
Our team combines deep clinical oncology expertise, world-class organoid and translational research, and strong operational leadership. We plan to strengthen regulatory, reimbursement, commercial scaling, and AI engineering capabilities to support international growth.
